The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Mag 440
Megnesium Oxide · MAGNESIUM OXIDE 440 mg/1 · Tablet · Oral · Allegis Pharmaceuticals, LLC
NDC 28595-0710-40 · 40 TABLET in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicaid spend (2025)
$29,466
72 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M001
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Megnesium Oxide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Allegis Pharmaceuticals, LLC | MAGNESIUM OXIDE 440 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Mag 440 — NDC 28595-0710-40," retrieved September 3, 2026, https://drugdashboards.com/drug/28595071040.
Free to cite with attribution — see how the data is put together.